Log in to save to my catalogue

Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted ar...

Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted ar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5d5e20daa8546fc963f77c256a102f8

Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy

About this item

Full title

Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy

Publisher

London: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2022-02, Vol.20 (1), p.88-88, Article 88

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Atherosclerosis (AS) is a leading cause of vascular diseases that severely threats the human health due to the lack of efficient therapeutic methods. During the development and progress of AS, macrophages play critical roles, which are polarized into pro-inflammatory M1 phenotype to excrete abundant cytokines and overproduce reactive oxygen species...

Alternative Titles

Full title

Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b5d5e20daa8546fc963f77c256a102f8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5d5e20daa8546fc963f77c256a102f8

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-022-01296-x

How to access this item